Illumina Inc (NASDAQ:ILMN)
| 195.86 Delayed Data As of May 26 |  +2.33 / +1.20%Today’s Change | 173.45 Today|||52-Week Range 258.07 | -3.14% Year-to-Date |
Latest ILMN News | Press Releases
| Baillie Gifford Dumps Salesforce, Loads Up on AMD May 26 / GuruFocus News - Paid Partner Content | Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now? May 24 / Zacks.com - Paid Partner Content |
| Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)? May 25 / Zacks.com - Paid Partner Content | Illumina (ILMN) Progresses in Pathogen Genomic Technologies May 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 193.53 |
| Today’s open | 195.50 |
| Day’s range | 194.97 - 199.57 |
| Volume | 102,061 |
| Average volume (3 months) | 1,259,186 |
| Market cap | $32.4B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -652.18% |
| Earnings growth (this year) | -36.57% |
| Earnings growth (next 5 years) | +2.10% |
| Revenue growth (last year) | +1.28% |
| P/E ratio | NM |
| Price/Sales | 6.93 |
| Price/Book | 4.90 |
Competitors
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | July 31, 2023 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $4.6B |
| Annual profit (last year) | -$4.4B |
| Net profit margin | -96.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
